tiprankstipranks
Trending News
More News >
Aspen Pharmacare Holdings Limited (APNHF)
OTHER OTC:APNHF

Aspen Pharmacare Holdings (APNHF) Price & Analysis

Compare
16 Followers

APNHF Stock Chart & Stats

$7.38
$0.25(2.04%)
At close: 4:00 PM EDT
$7.38
$0.25(2.04%)

APNHF FAQ

What was Aspen Pharmacare Holdings Limited’s price range in the past 12 months?
Aspen Pharmacare Holdings Limited lowest stock price was $5.10 and its highest was $12.24 in the past 12 months.
    What is Aspen Pharmacare Holdings Limited’s market cap?
    Aspen Pharmacare Holdings Limited’s market cap is $3.28B.
      When is Aspen Pharmacare Holdings Limited’s upcoming earnings report date?
      Aspen Pharmacare Holdings Limited’s upcoming earnings report date is Mar 03, 2026 which is in 44 days.
        How were Aspen Pharmacare Holdings Limited’s earnings last quarter?
        Aspen Pharmacare Holdings Limited released its earnings results on Sep 03, 2025. The company reported -$0.425 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.425.
          Is Aspen Pharmacare Holdings Limited overvalued?
          According to Wall Street analysts Aspen Pharmacare Holdings Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Aspen Pharmacare Holdings Limited pay dividends?
            Aspen Pharmacare Holdings Limited pays a Notavailable dividend of $0.122 which represents an annual dividend yield of 1.52%. See more information on Aspen Pharmacare Holdings Limited dividends here
              What is Aspen Pharmacare Holdings Limited’s EPS estimate?
              Aspen Pharmacare Holdings Limited’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Aspen Pharmacare Holdings Limited have?
              Aspen Pharmacare Holdings Limited has 446,252,320 shares outstanding.
                What happened to Aspen Pharmacare Holdings Limited’s price movement after its last earnings report?
                Aspen Pharmacare Holdings Limited reported an EPS of -$0.425 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.399%.
                  Which hedge fund is a major shareholder of Aspen Pharmacare Holdings Limited?
                  Currently, no hedge funds are holding shares in APNHF
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Aspen Pharmacare Holdings Limited

                    Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

                    Aspen Pharmacare Holdings (APNHF) Earnings & Revenues

                    APNHF Company Deck

                    APNHF Earnings Call

                    Q4 2025
                    0:00 / 0:00
                    Earnings Call Sentiment|Neutral
                    The earnings call highlighted strong performance in the Commercial Pharma segment and strategic advancements in the GLP-1 space, but also revealed significant challenges in the Manufacturing sector and external pressures from tax and currency fluctuations. The sentiment leans towards being cautiously optimistic due to strong commercial performance, but with recognition of the hurdles in Manufacturing and external financial pressures.View all APNHF earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Bristol-Myers Squibb
                    Dr Reddy's Laboratories
                    Pfizer
                    Bausch Health Companies
                    Sanofi
                    Teva Pharmaceutical
                    Popular Stocks